{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:44:55Z","timestamp":1791985495962,"version":"4.4.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T00:00:00Z","timestamp":1370390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1038\/npp.2013.143","type":"journal-article","created":{"date-parts":[[2013,6,5]],"date-time":"2013-06-05T05:52:27Z","timestamp":1370411547000},"page":"2427-2438","source":"Crossref","is-referenced-by-count":41,"title":["Effects of Acute Oral Naltrexone on the Subjective and Physiological Effects of Oral D-Amphetamine and Smoked Cocaine in Cocaine Abusers"],"prefix":"10.1038","volume":"38","author":[{"given":"Sandra D","family":"Comer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanthi","family":"Mogali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip A","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Askalsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen A","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jermaine D","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne K","family":"Vosburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziva D","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne M","family":"Manubay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Pines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L","family":"Berkower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard W","family":"Foltin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,6,5]]},"reference":[{"key":"BFnpp2013143_CR1","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1037\/1064-1297.16.2.113","volume":"16","author":"A Acheson","year":"2008","unstructured":"Acheson A, de Wit H (2008). Buproprion improves attention but does not affect impulsive behavior in healthy young adults. Exp Clin Psychopharmacol 16: 113\u2013123.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp2013143_CR2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/00004714-199602000-00012","volume":"16","author":"LH Brauer","year":"1996","unstructured":"Brauer LH, Ambre J, de Wit H (1996). Acute tolerance to subjective but not cardiovascular effects of d-amphetamine in normal, healthy men. J Clin Psychopharmacol 16: 72\u201376.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2013143_CR3","first-page":"103","volume":"11","author":"C Burattini","year":"2008","unstructured":"Burattini C, Burbassi S, Aicardi G, Cervo L (2008). Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats. Int J Neurospychopharmacol 11: 103\u2013109.","journal-title":"Int J Neurospychopharmacol"},{"key":"BFnpp2013143_CR4","first-page":"1","volume":"238","author":"ME Carroll","year":"1986","unstructured":"Carroll ME, Lac ST, Walker MJ, Kragh R, Newman T (1986). Effects of naltrexone on intravenous cocaine self-administration in rats during food satiation and deprivation. J Pharmacol Exp Ther 238: 1\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2013143_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02805973","volume":"127","author":"SD Comer","year":"1996","unstructured":"Comer SD, Haney M, Foltin RW, Fischman MW (1996). Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology 127: 39\u201346.","journal-title":"Psychopharmacology"},{"key":"BFnpp2013143_CR6","first-page":"1470","volume":"267","author":"SD Comer","year":"1993","unstructured":"Comer SD, Lac ST, Curtis LK, Carroll ME (1993). Effects of buprenorphine and naltrexone on reinstatement of cocaine-reinforced responding in rats. J Pharmacol Exp Ther 267: 1470\u20131477.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2013143_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1001\/archpsyc.63.2.210","volume":"63","author":"SD Comer","year":"2006","unstructured":"Comer SD, Sullivan MA, Yu E, Rothenberg JL, Kleber HD, Kampman K et al (2006). Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial. Arch Gen Psychiatry 63: 210\u2013218.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013143_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF02244173","volume":"104","author":"WA Corrigall","year":"1991","unstructured":"Corrigall WA, Coen KM (1991). Opiate antagonists reduce cocaine but not nicotine self-administration. Psychopharmacology 104: 167\u2013170.","journal-title":"Psychopharmacology"},{"key":"BFnpp2013143_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2011.06.023","volume":"120","author":"A DeFulio","year":"2012","unstructured":"DeFulio A, Everly JJ, Leoutsakos JMS, Umbricht A, Fingerhood M, Bigelow GE et al (2012). Employment-based reinforcement of adherence to an FDA approved extended release formulation of naltrexone in opioid-dependent adults: a randomized controlled trial. Drug Alcohol Depend 120: 48\u201354.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2013143_CR10","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1037\/a0030743","volume":"21","author":"KE Dunn","year":"2012","unstructured":"Dunn KE, Defulio A, Everly JJ, Donlin WD, Aklin WM, Nuzzo PA et al (2012). Employment-based reinforcement of adherence to oral naltrexone treatment in unemployed injection drug users. Exp Clin Psychopharmacol 21: 74\u201383.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp2013143_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.addbeh.2009.11.003","volume":"35","author":"DH Epstein","year":"2010","unstructured":"Epstein DH, Marrone GF, Heishman SJ, Schmittner J, Preston KL (2010). Tobacco, cocaine, and heroin: Craving and use during daily life. Addictive Behav 35: 318\u2013324.","journal-title":"Addictive Behav"},{"key":"BFnpp2013143_CR12","first-page":"204","volume":"78","author":"A Ettenberg","year":"1982","unstructured":"Ettenberg A, Pettit HO, Bloom FE, Koob GF (1982). Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems. Pharmacology 78: 204\u2013209.","journal-title":"Pharmacology"},{"key":"BFnpp2013143_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1037\/1064-1297.13.3.200","volume":"13","author":"MT Fillmore","year":"2005","unstructured":"Fillmore MT, Rush CR, Abroms BD (2005). D-amphetamine-induced enhancement of inhibitory mechanisms involved in visual search. Exp Clin Psychopharmacol 13: 200\u2013208.","journal-title":"Exp Clin Psychopharmacol"},{"key":"BFnpp2013143_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0376-8716(03)00089-9","volume":"71","author":"MT Fillmore","year":"2003","unstructured":"Fillmore MT, Rush CR, Marczinski CA (2003). Effects of d-amphetamine on behavioral control in stimulant abusers: the role of prepotent response tendencies. Drug Alcohol Depend 71: 143\u2013152.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2013143_CR15","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0376-8716(02)00343-5","volume":"70","author":"RW Foltin","year":"2003","unstructured":"Foltin RW, Ward AS, Haney M, Hart CL, Collins ED (2003). The effects of escalating doses of smoked cocaine in humans. Drug Alcohol Depend 70: 149\u2013157.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2013143_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.euroneuro.2004.11.004","volume":"15","author":"MAFM Gerrits","year":"2005","unstructured":"Gerrits MAFM, Kuzmin AV, van Ree JM (2005). Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone. Eur Neuropsychopharmacol 15: 297\u2013303.","journal-title":"Eur Neuropsychopharmacol"},{"key":"BFnpp2013143_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00213-012-2949-9","volume":"227","author":"C Giuliano","year":"2013","unstructured":"Giuliano C, Robbins TW, Wille DR, Bullmore ET, Everritt BJ (2013). Attenuation of cocaine and heroin seeking by \u03bc-opioid receptor antagonism. Psychopharmacology 227: 137\u2013147.","journal-title":"Psychopharmacology"},{"key":"BFnpp2013143_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","volume":"29","author":"J Grabowski","year":"2004","unstructured":"Grabowski J, Shearer J, Merrill J, Negus SS (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addict Behav 29: 1439\u20131464.","journal-title":"Addict Behav"},{"key":"BFnpp2013143_CR19","first-page":"397","volume":"22","author":"W Guy","year":"1986","unstructured":"Guy W, Wilson WH, Brooking B, Manov G, Fjetland O (1986). Reliability and validity of SAFTEE: preliminary analyses. Psychopharmacol Bull 22: 397\u2013401.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp2013143_CR20","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1369-1600.2009.00150.x","volume":"14","author":"J Haggkvist","year":"2009","unstructured":"Haggkvist J, Lindholm S, Frank J (2009). The effect of naltrexone on amphetamine-induced conditioned place preference and locomotor behaviour in the rat. Addict Biol 14: 260\u2013269.","journal-title":"Addict Biol"},{"key":"BFnpp2013143_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s002130050688","volume":"139","author":"D Hersh","year":"1998","unstructured":"Hersh D, Van Kirk JR, Kranzler HR (1998). Naltrexone treatment of comorbid alcohol and cocaine use disorders. Psychopharmacology 139: 44\u201352.","journal-title":"Psychopharmacology"},{"key":"BFnpp2013143_CR22","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1176\/appi.ajp.2008.08020304","volume":"165","author":"N Jayaram-Lindstrom","year":"2008","unstructured":"Jayaram-Lindstrom N, Hammarberg A, Beck O, Franck J (2008a). Naltrexone for the treatment of amphetamine dependence: a randomized, placebo-controlled trial. Am J Psychiatry 165: 1442\u20131448.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013143_CR23","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1038\/sj.npp.1301572","volume":"33","author":"N Jayaram-Lindstrom","year":"2008","unstructured":"Jayaram-Lindstrom N, Konstenius M, Eksborg S, Beck O, Hammarberg A, Franck J (2008b). Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependence. Neuropsychopharmacology 33: 1856\u20131863.","journal-title":"Neuropsychopharmacology"},{"key":"BFnpp2013143_CR24","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/01.jcp.0000144893.29987.e5","volume":"24","author":"N Jayaram-Lindstrom","year":"2004","unstructured":"Jayaram-Lindstrom N, Wennberg P, Hurd YL, Franck J (2004). Effects of naltrexone on the subjective response to ampthetamine in healthy volunteers. J Clin Psychopharmacol 24: 665\u2013669.","journal-title":"J Clin Psychopharmacol"},{"key":"BFnpp2013143_CR25","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/FBP.0b013e3283423d55","volume":"22","author":"C Jimenez-Gomez","year":"2011","unstructured":"Jimenez-Gomez C, Winger G, Dean RL, Deaver DR, Woods JH (2011). Naltrexone decreases d-amphetamine and ethanol self-administration in rhesus monkeys. Behav Pharmacol 22: 87\u201390.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2013143_CR26","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/S0091-3057(00)00258-6","volume":"66","author":"AC King","year":"2000","unstructured":"King AC, Meyer PJ (2000). Naltrexone alteration of acute smoking response in nicotine-dependent subjects. Pharmacol Biochem Behav 66: 563\u2013572.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013143_CR27","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/0024-3205(89)90589-4","volume":"44","author":"TR Kosten","year":"1989","unstructured":"Kosten TR, Kleber HD, Morgan C (1989). Role of opioid antagonists in treating intravenous cocaine abuse. Life Sci 44: 887\u2013892.","journal-title":"Life Sci"},{"key":"BFnpp2013143_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/0006-3223(92)90223-M","volume":"32","author":"T Kosten","year":"1992","unstructured":"Kosten T, Silverman DG, Fleming J, Kosten TA, Gawin FH, Compton M et al (1992). Intravenous cocaine challenges during naltrexone maintenance: a preliminary study. Biol Psychiatry 32: 543\u2013548.","journal-title":"Biol Psychiatry"},{"key":"BFnpp2013143_CR29","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.psc.2012.03.012","volume":"35","author":"JJ Mariani","year":"2012","unstructured":"Mariani JJ, Levin FR (2012). Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am 35: 425\u2013439.","journal-title":"Psychiatr Clin North Am"},{"key":"BFnpp2013143_CR30","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1176\/ajp.2007.164.4.622","volume":"164","author":"D Martinez","year":"2007","unstructured":"Martinez D, Narendran R, Foltin RW, Slifstein M, Hwang DR, Broft A et al (2007). Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 164: 622\u2013629.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2013143_CR31","first-page":"225","volume":"166","author":"ME McCaul","year":"1996","unstructured":"McCaul ME, Svikis DS (1996). Measures of service utilization. NIDA Res Monogr 166: 225\u2013241.","journal-title":"NIDA Res Monogr"},{"key":"BFnpp2013143_CR32","first-page":"1325","volume":"274","author":"NK Mello","year":"1995","unstructured":"Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW, Drieze J (1995). A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 274: 1325\u20131337.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2013143_CR33","first-page":"15","volume":"45","author":"MC Meyer","year":"1984","unstructured":"Meyer MC, Straughn AB, Man-Wai L, Schary WL, Whitney CC (1984). Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration. J Clin Psychiatry 45: 15\u201319.","journal-title":"J Clin Psychiatry"},{"key":"BFnpp2013143_CR34","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0740-5472(98)00039-7","volume":"16","author":"DW Oslin","year":"1999","unstructured":"Oslin DW, Pettinati HM, Volpicello JR, Wolf AL, Kampman KM, O\u2019Brien CP (1999). The effects of naltrexone on alcohol and cocaine use in dually addicted patients. J Subst Abuse Treat 16: 163\u2013167.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp2013143_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.drugalcdep.2007.10.002","volume":"93","author":"P Paliwal","year":"2008","unstructured":"Paliwal P, Hyman SM, Sinha R (2008). Craving predicts time to cocaine relapse: Further validation of the Now and Brief versions of the cocaine craving questionnaire. Drug Alcohol Depend 93: 252\u2013259.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2013143_CR36","first-page":"389","volume":"22","author":"JG Rabkin","year":"1986","unstructured":"Rabkin JG, Markowitz JS (1986). Side effect assessment with SAFTEE: pilot study of the instrument. Psychopharmacol Bull 22: 389\u2013396.","journal-title":"Psychopharmacol Bull"},{"key":"BFnpp2013143_CR37","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/0091-3057(91)90090-O","volume":"40","author":"NF Ramsey","year":"1991","unstructured":"Ramsey NF, van Ree JM (1991). Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol Biochem Behav 40: 807\u2013810.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013143_CR38","unstructured":"Reed SC, Evans SM (2010). The effects of oral d-amphetamine on impulsivity, mood and performance in smoked cocaine users [abstract]. In College on Problems of Drug Dependence. 2010 June 12\u201317. Scottsdale, Arizona. CPDD; 2010. p 136. Abstract nr 542."},{"key":"BFnpp2013143_CR39","doi-asserted-by":"publisher","first-page":"356","DOI":"10.3109\/10550490903077929","volume":"18","author":"JM Schmitz","year":"2009","unstructured":"Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Moeller FG (2009). High-dose naltrexone therapy for cocaine-alcohol dependence. Am J Addiction 18: 356\u2013362.","journal-title":"Am J Addiction"},{"key":"BFnpp2013143_CR40","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S0306-4603(00)00098-8","volume":"26","author":"JM Schmitz","year":"2001","unstructured":"Schmitz JM, Stotts AL, Rhoades HM, Grabowski J (2001). Naltrexone and relapse prevention treatment for cocaine-dependent patients. Addict Behav 26: 167\u2013180.","journal-title":"Addict Behav"},{"key":"BFnpp2013143_CR41","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/FBP.0b013e32833fa7b3","volume":"21","author":"RJ Sevak","year":"2010","unstructured":"Sevak RJ, Stoops WW, Glaser PEA, Hays LR, Rush CR (2010). Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule. Behav Pharmacol 21: 745\u2013753.","journal-title":"Behav Pharmacol"},{"key":"BFnpp2013143_CR42","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S0091-3057(03)00157-6","volume":"75","author":"M Sofuoglu","year":"2003","unstructured":"Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A (2003). Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacol Biochem Behav 75: 801\u2013808.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013143_CR43","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/0091-3057(84)90017-0","volume":"20","author":"J Stewart","year":"1984","unstructured":"Stewart J (1984). Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area. Pharmacol Biochem Behav 20: 917\u2013923.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013143_CR44","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1177\/026988110401800411","volume":"18","author":"WW Stoops","year":"2004","unstructured":"Stoops WW, Glaser PEA, Fillmore MT, Rush CR (2004). Reinforcing, subject-rated, performance and physiological effects of methylphenidate and d-amphetamine in stimulant abusing humans. J Psychopharmacol 18: 534\u2013543.","journal-title":"J Psychopharmacol"},{"key":"BFnpp2013143_CR45","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.pbb.2007.03.016","volume":"87","author":"WW Stoops","year":"2007","unstructured":"Stoops WW, Vansickel AR, Lile JA, Rush CR (2007). Acute d-amphetamine pretreatment does not alter stimulant self-administration in humans. Pharmacol Biochem Behav 87: 20\u201329.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFnpp2013143_CR46","unstructured":"Substance Abuse and Mental Health Services Administration, Center for Behavioral Health Statistics and Quality (2012) The DAWN Report: Highlights of the 2010 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD, USA."},{"key":"#cr-split#-BFnpp2013143_CR47.1","unstructured":"Substance Abuse and Mental Health Services Administration (2012) Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings NSDUH Series H-44, HHS Publication No."},{"key":"#cr-split#-BFnpp2013143_CR47.2","unstructured":"(SMA) 12-4713 Substance Abuse and Mental Health Services Administration, 2012: Rockville, MD, USA."},{"key":"BFnpp2013143_CR48","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1111\/j.1369-1600.2009.00161.x","volume":"14","author":"MS Todtenkopf","year":"2009","unstructured":"Todtenkopf MS, O\u2019Neill KS, Kriksciukaite K, Turncliff RZ, Dean RL, Ostrovsky-Day I et al (2009). Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats. Addict Biol 14: 408\u2013418.","journal-title":"Addict Biol"},{"key":"BFnpp2013143_CR49","unstructured":"United Nations Office on Drugs and Crime, World Drug Report (2011). United Nations Publication, Sales No. E. 10. XI. 13."},{"key":"BFnpp2013143_CR50","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1001\/archpsyc.1992.01820110040006","volume":"49","author":"JR Volpicelli","year":"1992","unstructured":"Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992). Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876\u2013880.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp2013143_CR51","first-page":"369","volume":"9","author":"ME Wall","year":"1981","unstructured":"Wall ME, Brine DR, Perez-Reyes M (1981). Metabolism and disposition of naltrexone in man after oral and intravenous administration. Drug Metab Disposition 9: 369\u2013375.","journal-title":"Drug Metab Disposition"},{"key":"BFnpp2013143_CR52","first-page":"524","volume":"279","author":"SL Walsh","year":"1996","unstructured":"Walsh SL, Sullivan JT, Preston KL, Garner JE, Bigelow GE (1996). Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther 279: 524\u2013538.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2013143_CR53","first-page":"311","volume":"261","author":"G Winger","year":"1992","unstructured":"Winger G, Skjoldager P, Woods JH (1992). Effects of buprenorphine and other opioid agonists and antagonists on alfentanil- and cocaine-reinforced responding in rhesus monkeys. J Pharmacol Exp Ther 261: 311\u2013317.","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2013143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2013143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:44:46Z","timestamp":1684439086000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2013143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,5]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["BFnpp2013143"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.143","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718026172.793480741","asserted-by":"object"}]},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,5]]}}}